Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Insights and Consensus from Experts on Bridging Therapy Prior to Anti-BCMA CAR-T Treatment in Multiple Myeloma

  • By

  • Leo Rasche

  • Maria Theresa Krauth

  • Hermine Agis

  • Christoph Renner

  • Irene Strassl

  • Raphael Teipel

  • Vladan Vučinić

  • Katja Weisel

  • Wolfgang Willenbacher

  • Marc S. Raab

  • May 13, 2026

Share

Original Source(s)

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma

  • by Leo Rasche, Maria Theresa Krauth, Hermine Agis, Christoph Renner, Irene Strassl, Raphael Teipel, Vladan Vučinić, Katja Weisel, Wolfgang Willenbacher, Marc S. Raab

  • May 13, 2026

Related Content

Retraction Note: Lycorine inhibits angiogenesis by docking to PDGFRα

The evolution of RTOG and NRG Oncology CNS tumors clinical trials

Cost-Effectiveness of Electronic Patient-Reported Outcome Measure Interventions in Cancer: Systematic Review and Parameter Extraction for Economic Modeling